Chloe received her Biomedical Sciences degree (with honours) in 2011 from the University of Reading. She then went on to complete an MSc in Epidemiology and Biostatistics at the University of Leeds in 2013. For her Masters dissertation project, Chloe looked at penalised regression methods for the fine-mapping of genetic-susceptibility loci for Melanoma using data collected by the GenoMEL consortium.
In 2013, Chloe began her PhD at the University of Birmingham within the Centre for Childhood Cancer Survivor Study Studies where she is currently working on the Teenage and Young Adult Cancer Survivor Study (TYACSS) and the PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies (PanCareSurFup). Chloe’s research will be assessing the long-term adverse effects of treatments in survivors of teenage and young adult cancer.
Teenage and Young Adult Cancer Survivor Study
The TYACSS is a British cohort of about 300,000 individuals diagnosed with cancer in teenage and young adult (age 15-39, inclusive). The cohort will be linked to NHS central registries and Hospital Episodes Statistics (HES) to investigate adverse health outcomes among these individuals.
PanCareSurFup is an EU funded European wide study into the risks of adverse effects of treatment for childhood cancer.